Orodispersible Tablets Market Synopsis:
Orodispersible Tablets Market Size Was Valued at USD 9.30 Billion in 2023, and is Projected to Reach USD 23.41 Billion by 2032, Growing at a CAGR of 10.8% From 2024-2032.
The Orodispersible Tablets Market means the pharmaceutical industry niche that offers tablets, which disintegrate in the mouth without the use of water within a short time, and therefore, predictably increasing patients’ compliance. These tablets are also advantageous to children, the elderly, and patients with swallowing problems and little access to water.
The Markets for Orodispersible Tablets has grown considerably over the years mainly due to the increasing need for good patient compliance associated with diseases and the most basic and attractive method of getting drugs into the body. They help to improve the quality of the patient’s stay by eradicating the problems that come along with the swallowing of standard tablets and capsules. Not only do they dissolve faster to enhance drug adherence but also retain their quick action profiles as agents for acute and chronic illnesses management. The market has been boosted by new opportunities in the pharmaceutical industry such as new excipients and technologies for the development of orodispersible formulations, increasing stability and effectiveness of Orodispersible products.
Also, its market has a wide demand for chronic diseases like cardiovascular, pain management, and mental health ailments. These factors coupled with the increasing knowledge of the use and benefits the orodispersible tablets by healthcare practitioners as well as patients of therapeutic systems have made it develop in a wide variety of therapeutic uses. There is also a significant shift for the new pharmaceutical products to introduce enhanced flavors and technologies to suit the clients in ways that patients such as children and the elderly can accept to take them without defaulting.
Orodispersible Tablets Market Trend Analysis:
Technological Innovations in Orodispersible Tablet Formulation
- The future outlook of the Orodispersible Tablets Market is characterized primarily by the active use of new technological approaches, enabling improved characteristics of the products and increased comfort for the consumer. Technologies like lyophilization, sublimation and Direct compression are being used to formulate tablets which show faster disintegration time and better taste-masking. These innovations allow for the formulation, not only of a very effective medicine but of one that can be patient-specific – children by having a flavored liquid, when handling adult formulations that require a more potent treatment. In addition, the ability to incorporate API’S into orodispersible forms is also widening the scope of the therapeutic uses, which in a way is propelling this market forward.
Rising Demand in Emerging Economies
- New economies promise significant growth for the Orodispersible Tablets Market due to improved awareness of health, improved consumer income and increased accessibility of health care facilities. There has been an increased need for affordable and convenient-to-administer drugs in areas including Asia-Pacific, Latin America and African continent especially in the rural setting where water may be scarce. These opportunities have been effectively being exploited by pharmaceutical industries through the introduction of new cheaper forms of orodispersible tablets that are better suited to the local environment hence improving access to health by expanding the market globally.
Orodispersible Tablets Market Segment Analysis:
The orodispersible Tablets Market is Segmented on the basis of drug class, disease indication, distribution channel, and region
By Drug Class, Analgesics segment is expected to dominate the market during the forecast period
- The OPAT market is expected to be leaded by the segment known as Analgesics throughout the period of the study. This dominance is as a result of increase in incidence of acute and chronic pain such as arthritis, migraines and postoperative pain that require rapid relief. Orodispersible tablets again start working more quickly and therefore pain relief can be effectively achieved with the help of the medicine. Also, more patients preferring these tablets tend to have problems in swallowing the usual pain alleviation tablets hence, encouraging use of these tablets. The pharmaceuticals are investing more on research and about creation of new and improved formulation, having better bioavailability with or without side effects, thus making sure that the analgesics segment continues to help the market grow.
By Disease Indication, the Pain Management segment expected to held the largest share
- Pain Management is forecasted to be the largest Orodispersible Tablets Market considering the growing instances of pain-related diseases and rising consumers’ preference for easy to swallow caplets. Orodispersible tablets are an excellent option for administering pain relief where patients require instant pain relief or patients who have problems with swallowing conventional tablets. This segment’s growth is also supported by the development of new formulations for particular types of pain, including neuropathic and cancer pain, and increasing use of these tablets in both clinical practice and home treatment.
Orodispersible Tablets Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- North American region will exhibit the highest market shares in the global Orodispersible Tablets Market over the forecast period due to factors such as increased healthcare spending, developed pharmacy networks, and specialized concentrates on patient-centered drug delivery systems. The main driver of the market in the overall context is the ongoing adoption of advanced healthcare solutions, combined with the key roles of top pharma players from the United States. A higher incidence of chronic diseases like cardiovascular diseases and mental disorders has also acted as driver to the demand for orodispersible tablets in the region.
- Furthermore, the market has entered a growth phase in North America due to friendly policies and escalating coverage about orodispersible tablets among medical practitioner and patients. The companies operating in the region have directed a lot of efforts in making new development to bring in new formulations and to cater for the various groups of people in a region.
Active Key Players in the Orodispersible Tablets Market:
- Actavis (Ireland)
- AstraZeneca (United Kingdom)
- Bayer AG (Germany)
- Catalent, Inc. (United States)
- Cipla Ltd. (India)
- Dr. Reddy’s Laboratories (India)
- GlaxoSmithKline plc (United Kingdom)
- Johnson & Johnson (United States)
- Merck & Co., Inc. (United States)
- Mylan N.V. (United States)
- Novartis AG (Switzerland)
- Pfizer Inc. (United States)
- Ranbaxy Laboratories Ltd. (India)
- Sun Pharmaceutical Industries Ltd. (India)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Other Active Players
|
Global Orodispersible Tablets Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 9.30 Billion |
|
Forecast Period 2024-32 CAGR: |
10.8% |
Market Size in 2032: |
USD 23.41 Billion |
|
Segments Covered: |
By Drug Class |
|
|
|
By Disease Indication |
|
||
|
By Distribution Channel |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Orodispersible Tablets Market by By Drug Class (2018-2032)
4.1 Orodispersible Tablets Market Snapshot and Growth Engine
4.2 Market Overview
4.3 Analgesics
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
4.3.3 Key Market Trends, Growth Factors, and Opportunities
4.3.4 Geographic Segmentation Analysis
4.4 Antiemetics
4.5 Antipsychotics
4.6 Anti-inflammatory drugs
4.7 Sedatives/Hypnotics
4.8 Antihypertensives
4.9 Others
Chapter 5: Orodispersible Tablets Market by By Disease Indication (2018-2032)
5.1 Orodispersible Tablets Market Snapshot and Growth Engine
5.2 Market Overview
5.3 Pain Management
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
5.3.3 Key Market Trends, Growth Factors, and Opportunities
5.3.4 Geographic Segmentation Analysis
5.4 Allergy and Respiratory Disorders
5.5 Neurological Disorders
5.6 Gastrointestinal Disorders
5.7 Cardiovascular Disorders
5.8 Others
Chapter 6: Orodispersible Tablets Market by By Distribution Channel (2018-2032)
6.1 Orodispersible Tablets Market Snapshot and Growth Engine
6.2 Market Overview
6.3 Hospital Pharmacies
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units
6.3.3 Key Market Trends, Growth Factors, and Opportunities
6.3.4 Geographic Segmentation Analysis
6.4 Retail Pharmacies
6.5 Online Pharmacies
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Orodispersible Tablets Market Share by Manufacturer (2024)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 ACTAVIS (IRELAND)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 ASTRAZENECA (UNITED KINGDOM)
7.4 BAYER AG (GERMANY)
7.5 CATALENT INC. (UNITED STATES)
7.6 CIPLA LTD. (INDIA)
7.7 DR. REDDY’S LABORATORIES (INDIA)
7.8 GLAXOSMITHKLINE PLC (UNITED KINGDOM)
7.9 JOHNSON & JOHNSON (UNITED STATES)
7.10 MERCK & CO. INC. (UNITED STATES)
7.11 MYLAN N.V. (UNITED STATES)
7.12 NOVARTIS AG (SWITZERLAND)
7.13 PFIZER INC. (UNITED STATES)
7.14 RANBAXY LABORATORIES LTD. (INDIA)
7.15 SUN PHARMACEUTICAL INDUSTRIES LTD. (INDIA)
7.16 TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
7.17 OTHER ACTIVE PLAYERS
Chapter 8: Global Orodispersible Tablets Market By Region
8.1 Overview
8.2. North America Orodispersible Tablets Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By By Drug Class
8.2.4.1 Analgesics
8.2.4.2 Antiemetics
8.2.4.3 Antipsychotics
8.2.4.4 Anti-inflammatory drugs
8.2.4.5 Sedatives/Hypnotics
8.2.4.6 Antihypertensives
8.2.4.7 Others
8.2.5 Historic and Forecasted Market Size By By Disease Indication
8.2.5.1 Pain Management
8.2.5.2 Allergy and Respiratory Disorders
8.2.5.3 Neurological Disorders
8.2.5.4 Gastrointestinal Disorders
8.2.5.5 Cardiovascular Disorders
8.2.5.6 Others
8.2.6 Historic and Forecasted Market Size By By Distribution Channel
8.2.6.1 Hospital Pharmacies
8.2.6.2 Retail Pharmacies
8.2.6.3 Online Pharmacies
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Orodispersible Tablets Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By By Drug Class
8.3.4.1 Analgesics
8.3.4.2 Antiemetics
8.3.4.3 Antipsychotics
8.3.4.4 Anti-inflammatory drugs
8.3.4.5 Sedatives/Hypnotics
8.3.4.6 Antihypertensives
8.3.4.7 Others
8.3.5 Historic and Forecasted Market Size By By Disease Indication
8.3.5.1 Pain Management
8.3.5.2 Allergy and Respiratory Disorders
8.3.5.3 Neurological Disorders
8.3.5.4 Gastrointestinal Disorders
8.3.5.5 Cardiovascular Disorders
8.3.5.6 Others
8.3.6 Historic and Forecasted Market Size By By Distribution Channel
8.3.6.1 Hospital Pharmacies
8.3.6.2 Retail Pharmacies
8.3.6.3 Online Pharmacies
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Orodispersible Tablets Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By By Drug Class
8.4.4.1 Analgesics
8.4.4.2 Antiemetics
8.4.4.3 Antipsychotics
8.4.4.4 Anti-inflammatory drugs
8.4.4.5 Sedatives/Hypnotics
8.4.4.6 Antihypertensives
8.4.4.7 Others
8.4.5 Historic and Forecasted Market Size By By Disease Indication
8.4.5.1 Pain Management
8.4.5.2 Allergy and Respiratory Disorders
8.4.5.3 Neurological Disorders
8.4.5.4 Gastrointestinal Disorders
8.4.5.5 Cardiovascular Disorders
8.4.5.6 Others
8.4.6 Historic and Forecasted Market Size By By Distribution Channel
8.4.6.1 Hospital Pharmacies
8.4.6.2 Retail Pharmacies
8.4.6.3 Online Pharmacies
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Orodispersible Tablets Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By By Drug Class
8.5.4.1 Analgesics
8.5.4.2 Antiemetics
8.5.4.3 Antipsychotics
8.5.4.4 Anti-inflammatory drugs
8.5.4.5 Sedatives/Hypnotics
8.5.4.6 Antihypertensives
8.5.4.7 Others
8.5.5 Historic and Forecasted Market Size By By Disease Indication
8.5.5.1 Pain Management
8.5.5.2 Allergy and Respiratory Disorders
8.5.5.3 Neurological Disorders
8.5.5.4 Gastrointestinal Disorders
8.5.5.5 Cardiovascular Disorders
8.5.5.6 Others
8.5.6 Historic and Forecasted Market Size By By Distribution Channel
8.5.6.1 Hospital Pharmacies
8.5.6.2 Retail Pharmacies
8.5.6.3 Online Pharmacies
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Orodispersible Tablets Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By By Drug Class
8.6.4.1 Analgesics
8.6.4.2 Antiemetics
8.6.4.3 Antipsychotics
8.6.4.4 Anti-inflammatory drugs
8.6.4.5 Sedatives/Hypnotics
8.6.4.6 Antihypertensives
8.6.4.7 Others
8.6.5 Historic and Forecasted Market Size By By Disease Indication
8.6.5.1 Pain Management
8.6.5.2 Allergy and Respiratory Disorders
8.6.5.3 Neurological Disorders
8.6.5.4 Gastrointestinal Disorders
8.6.5.5 Cardiovascular Disorders
8.6.5.6 Others
8.6.6 Historic and Forecasted Market Size By By Distribution Channel
8.6.6.1 Hospital Pharmacies
8.6.6.2 Retail Pharmacies
8.6.6.3 Online Pharmacies
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Orodispersible Tablets Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By By Drug Class
8.7.4.1 Analgesics
8.7.4.2 Antiemetics
8.7.4.3 Antipsychotics
8.7.4.4 Anti-inflammatory drugs
8.7.4.5 Sedatives/Hypnotics
8.7.4.6 Antihypertensives
8.7.4.7 Others
8.7.5 Historic and Forecasted Market Size By By Disease Indication
8.7.5.1 Pain Management
8.7.5.2 Allergy and Respiratory Disorders
8.7.5.3 Neurological Disorders
8.7.5.4 Gastrointestinal Disorders
8.7.5.5 Cardiovascular Disorders
8.7.5.6 Others
8.7.6 Historic and Forecasted Market Size By By Distribution Channel
8.7.6.1 Hospital Pharmacies
8.7.6.2 Retail Pharmacies
8.7.6.3 Online Pharmacies
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
|
Global Orodispersible Tablets Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 9.30 Billion |
|
Forecast Period 2024-32 CAGR: |
10.8% |
Market Size in 2032: |
USD 23.41 Billion |
|
Segments Covered: |
By Drug Class |
|
|
|
By Disease Indication |
|
||
|
By Distribution Channel |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Frequently Asked Questions :
The forecast period in the Orodispersible Tablets Market research report is 2024-2032.
Pfizer Inc., AstraZeneca, Novartis AG, Sun Pharmaceutical Industries Ltd., Johnson & Johnson, and Other Active Players.
The Orodispersible Tablets Market is segmented into Drug Class, Disease Indication, Distribution Channel and region. By Drug Class, the market is categorized into Analgesics Antiemetics Antipsychotics Anti-inflammatory Drugs Sedatives/Hypnotics Antihypertensives Others. By Disease Indication, the market is categorized into Pain Management Allergy and Respiratory Disorders Neurological Disorders Gastrointestinal Disorders Cardiovascular Disorders Others. By Distribution Channel, the market is categorized into Hospital Pharmacies Retail Pharmacies Online Pharmacies. By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
The Orodispersible Tablets Market means the pharmaceutical industry niche that offers tablets, which disintegrate in the mouth without the use of water within a short time, and therefore, predictably increasing patients’ compliance. These tablets are also advantageous to children, the elderly, and patients with swallowing problems and little access to water.
Orodispersible Tablets Market Size Was Valued at USD 9.30 Billion in 2023, and is Projected to Reach USD 23.41 Billion by 2032, Growing at a CAGR of 10.8% From 2024-2032.
